Bipartisan bill revealed to lower drug prices in US
The Senate Finance Committee has unveiled its bipartisan bill in an effort to lower drug prices, requiring drug manufacturers to justify price increases.
List view / Grid view
The Senate Finance Committee has unveiled its bipartisan bill in an effort to lower drug prices, requiring drug manufacturers to justify price increases.
FDA issues warning to a company that claimed its CBD products can be used to treat cancer and Alzheimer's disease.
An integrated Phase I/III trial has enrolled its first patient to test a biosimilar for denosumab to treat postmenopausal osteoporosis.
The FDA has announced that it has granted approval to the first nine generic drug applications for Pfizer’s Lyrica treatment.
Researchers have developed a model that describes how antibody solutions separate into different phases and could be used to anticipate the stability and shelf-life of drugs.
A vaccine containing the DNA of HIV is poised to enter a Phase II trial, making it the first vaccine of its kind to do so.
Orphan Drug Designation has been given to AR-501 for the treatment of lung infection in patients with cystic fibrosis.
The FDA has handed a CRL to Biohaven for its ALS treatment awaiting approval due to concerns regarding the medication’s API.
The global downstream processing market is predicted to witness record-breaking growth due to a surge in the adoption of biotech processes.
The US Food and Drug Administration (FDA) has given an investigational sickle cell medicine, crizanlizumab (SEG101), Priority Review.
FPS has recently cooperated with pharmaceutical industry experts in research on jet mills' practices in pharmaceutical industries.
New investment provides substantial new funding to fuel the next stage of Quotient’s growth.
The health minister for the Democratic Republic of the Congo has stated an experimental Ebola vaccine will not be trialled in the country.
An Indian pharmaceutical company was planning to shred quality control records ahead of an FDA inspection, found officials.
A new drug delivery system disguises chemo-therapeutics as fat in order to destroy tumours.